Press Enter to Main Content
您的瀏覽器似乎不支援JavaScript語法,但沒關係,這裡的JavaScript語法並不會影響到內容的陳述, 如需要選擇字級大小,IE6請利用鍵盤按住ALT鍵+ V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小, 而IE7或Firefox瀏覽器則可利用鍵盤 Ctrl + (+)放大(-)縮小來改變字型大小,如需要回到上一頁可使用瀏覽器提供的 Alt+左方向鍵(←) 快速鍵功能,列印可使用瀏覽器提供的(Ctrl+P)功能。
  • facebook
  • line
  • twitter
  • Print
  • Back

Regulations for Registration of Medicinal Products

  • Data Source:Department of Chinese Medicine and Pharmacy
  • Created:2017-12-22
  • Last Updated:2017-12-25

Regulations for Registration of Medicinal Products

In accordance with Article 39, 46 and 47 of the Pharmaceutical Affairs Act, the manufacturing and import of drugs shall be filed with the central competent health authority for registration and market approval. No manufacturing or importation of such drugs shall be allowed until a drug license is approved and issued. The official approval is required for any change, transfer or extension of drug license. The application criteria, review procedure, approval criteria, and other matters to be complied with shall be established in the Regulations for Registration of Medicinal Product by the central competent health authority. Considering that the Regulations for Registration of Medicinal Product is established for enhancing medication safety of the public, the competent authority issuing, changing or extending the drug license and, the companies and industries who manufacture or import drugs shall all comply with the regulation.